Biosensors Market by Application (Point of Care, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food Industry), Product (Wearable, Non-Wearable), Technology (Electrochemical, Piezoelectric, Optical) & Geography - Analysis & Forecast to 2020
The
total market was valued at $11.39 billion in 2013 and is expected to reach
$22.68 billion by 2020, at an estimated CAGR of 10.00% from 2014 to 2020.
The
major drivers identified for the growth of the biosensors market are the
emergence of nanotechnology/nano-biosensors, significant technological
advancements over the last few years, glucose monitoring for diabetic patients,
and increasing demand for home care and point-of-care devices
Browse 73 market data tables and 77 figures spread through 191
pages and in-depth TOC on “Biosensors Market - Analysis & Forecast to 2020”
The
biosensor is a sensing device, which consists of a combination of a specific
biological element and a transducer. This market is expected to witness a
prominent growth over the coming years. Driven by the need for better methods
for environmental monitoring and rapid pathogen detection, the biosensors
industry has also been expanding to encompass non-clinical applications such as
biodefense, environmental surveillance, and food industry. This market is a
diversified and competitive market with a large number of players.
The
POC diagnostics market has the largest market presence among all the end-user
markets of biosensors.
The key players in this market are Roche
Diagnostics Limited (U.K.), Alere Inc. (U.S.), Siemens Healthcare (Germany),
and Beckman Coulter, Inc. (U.S.).
The
biosensors market for different geographic regions, including North America,
Europe, Asia-Pacific, and the Rest of the World (RoW), has also been covered in
the report. North America was the largest market for biosensors as of 2013.
APAC has been the most promising market for biosensors over the forecast period
and is expected to grow at the highest CAGR among all the regions.
Inquiry
Before Buying :
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=798
The
report profiles the promising major players with a SWOT analysis of the key
players in the biosensors market. The market witnesses a series of new product
launch announcements and partnerships across the value chain. The key players
in this industry include F. Hoffmann-La Roche Ltd. (Switzerland), LifeScan Inc.
(U.S.), Bayer Healthcare AG (Germany), Abbott Point of Care Inc. (U.S.),
Medtronic (U.S.), Siemens Healthcare (Germany), and others.
No comments: